Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11596696 Combination therapy with an anti-CD25 antibody-drug conjugate

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 20, 2018
0
Date of Patent
March 7, 2023
0
Patent Application Number
16605708
0
Patent Citations
‌
US Patent 10081681 Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
‌
US Patent 10259882 Anti-OX40 antibodies
0
‌
US Patent 10479838 Antibodies to CD40 with enhanced agonist activity
‌
US Patent 10544225 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
‌
US Patent 10690674 Anti-GITR antibodies for cancer diagnostics
‌
US Patent 10695433 Pyrrolobenzodiazepine-antibody conjugates
0
‌
US Patent 10736903 Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
‌
US Patent 10751346 Pyrrolobenzodiazepine—anti-PSMA antibody conjugates
‌
US Patent 10946093 Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors
‌
US Patent 10780096 Pyrrolobenzodiazepine-antibody conjugates
0
•••
Patent Citations Received
‌
US Patent 11779650 Pyrrolobenzodiazepine-antibody conjugates
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11596696
0
Patent Primary Examiner
‌
Karl J Puttlitz
0

Find more entities like US Patent 11596696 Combination therapy with an anti-CD25 antibody-drug conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo